Category Archives: Patent Opposition

People living with hepatitis C and HIV challenge evergreening patents on lifesaving hepatitis C drugs in India

New Delhi, 10 July 2018: Delhi Network of Positive People (DNP+) has filed today two patent oppositions before the Indian patent office, challenging additional patent claims by US pharmaceutical corporation-Gilead Sciences for the hepatitis C medicines sofosbuvir and velpatasvir. These … Continue reading

Posted in Drug prices, Hepatitis C, Indian Patent Law, Patent, Patent Opposition, Sec 3 (d) | Tagged , | Leave a comment

The grounds for opposing patent applications for velpatasvir

Source: MSF | July 09, 2018 Gilead Sciences has applied for multiple patents on oral hepatitis C medicines – sofosbuvir and velpatasvir in India: not only limiting itself to basic patents but also staking claims on a number of additional … Continue reading

Posted in Patent linkage, Patent Opposition, Patent Term Extension, Patents | Leave a comment

The problem with high drug prices isn’t ‘foreign freeloading,’ it’s the patent system

by Tahir Amin, CNBC | June 27, 2018 One in four Americans are unable to fill prescriptions due to high prices. Today’s drug patent monopolies are stronger than at any point in the last century, raising prescription prices. Until the … Continue reading

Posted in Evergreening, Patent, Patent examination system, Patent Opposition, Uncategorized | Leave a comment

New laws needed now to save lives: FTPL statement on new IP policy

  Source: Fix the Patent Laws Intellectual property policy welcomed after nine years of development JOHANNESBURG, 31 MAY 2018 – Yesterday, after nine years of development, the Department of Trade and Industry (the dti) finally published the Intellectual Property Policy of the … Continue reading

Posted in Compulsory Licensing, Doha Declaration, Fix the patent law, Patent Opposition, Patent Term Extension, TRIPS, Uncategorized | Leave a comment

MSF Challenges Pfizer’s Monopoly on Lifesaving Pneumonia Vaccine in Korea

Doctors Without Borders urges Pfizer to drop unmerited patents that hinder access to lifesaving childhood vaccine worldwide  NEW YORK/SEOUL, FEBRUARY 6, 2018—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is in the process of submitting a legal … Continue reading

Posted in Patent, Patent Opposition, Uncategorized, Vaccines | Leave a comment

WHO on MSF patent challenge: a win in India could save lives

MSF’s unprecedented legal challenge of the patent on Pfizer’s pneumonia vaccine Prevenar 13 in India is a “rational … coherent” strategy which, if successful, could save lives by opening the way for cheaper vaccines, a WHO vaccine expert tells Development Today. The … Continue reading

Posted in Patent, Patent Opposition, Uncategorized, Vaccines | Leave a comment

Doctors Without Borders contests Pfizer’s patent on pneumonia vaccine

Pfizer has come under fire for holding exclusive patent rights that bars competition on its pneumonia vaccine worldwide, which is being challenged in patent litigations in several countries, an aid group said Monday. Doctors Without Borders will challenge Pfizer in … Continue reading

Posted in Patent, Patent examination system, Patent Opposition, Uncategorized, Vaccines | Leave a comment

MSF approaches Delhi High Court to challenge unmerited patent grant for pneumonia vaccine

New Delhi, 13 October 2017 – Médecins Sans Frontières/Doctors Without Borders India has filed a petition before the High Court of Delhi to overturn the patent granted on the pneumococcal conjugate vaccine (PCV) to the US pharmaceutical corporation Pfizer. Earlier … Continue reading

Posted in Indian Patent Law, Indian Patent Office, Patent, Patent examination system, Patent Opposition, Uncategorized | Tagged , , | Leave a comment

Pfizer patent for pneumonia drug could have a deadly impact on public health

India carries the world’s highest burden of pneumonia and accounts for nearly 20% of global infant pneumonia deaths Opinion piece: Leena Menghaney, The Hindustan Times India’s Patent Office has dealt a major setback to hopes for improved access to an … Continue reading

Posted in Indian Patent Law, Indian Patent Office, Patent, Patent Opposition, Uncategorized, Vaccines | Leave a comment

Dangerous pneumonia on the loose, but affordable vaccine to get tough to procure; uproar sparked off; reason will SHOCK you

Source: The Financial Express Access to affordable pneumococcal conjugate vaccine (PCV) will become tougher after the Indian patent office granted a patent to US pharma major Pfizer for its PCV13 product, marketed as Prevnar13. Access to affordable pneumococcal conjugate vaccine … Continue reading

Posted in Indian Patent Office, Patent, Patent Opposition, Uncategorized, Vaccines | Leave a comment